SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001746473-24-000057
Filing Date
2024-04-22
Accepted
2024-04-22 16:58:52
Documents
19
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A plrx-20240422.htm   iXBRL DEF 14A 864416
3 plrx-20240422_g1.jpg GRAPHIC 44873
4 plrx-20240422_g2.jpg GRAPHIC 12375
5 plrx-20240422_g3.jpg GRAPHIC 67927
6 plrx-20240422_g4.jpg GRAPHIC 68515
7 plrx-20240422_g5.jpg GRAPHIC 429373
8 plrx-20240422_g6.jpg GRAPHIC 200489
9 plrx-20240422_g7.jpg GRAPHIC 121599
10 plrx-20240422_g8.jpg GRAPHIC 119446
  Complete submission text file 0001746473-24-000057.txt   3978662

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20240422.xsd EX-101.SCH 916
22 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20240422_htm.xml XML 148141
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39303 | Film No.: 24861854
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)